163 related articles for article (PubMed ID: 19286369)
1. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.
Rakha EA; Aleskandarany M; El-Sayed ME; Blamey RW; Elston CW; Ellis IO; Lee AH
Eur J Cancer; 2009 Jul; 45(10):1780-7. PubMed ID: 19286369
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
3. Classification and grading of invasive breast carcinoma.
Elston CW
Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670
[TBL] [Abstract][Full Text] [Related]
4. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
5. A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study.
Chaiwun B; Nakrungsee S; Sukhamwang N; Srisukho S
Breast Cancer; 2010; 17(1):35-41. PubMed ID: 19789946
[TBL] [Abstract][Full Text] [Related]
6. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
Rodríguez-Pinilla SM; Rodríguez-Gil Y; Moreno-Bueno G; Sarrió D; Martín-Guijarro Mdel C; Hernandez L; Palacios J
Am J Surg Pathol; 2007 Apr; 31(4):501-8. PubMed ID: 17414096
[TBL] [Abstract][Full Text] [Related]
7. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
8. [Typical medullary carcinoma of the breast: a retrospective study about 33 cases].
Khomsi F; Ben Bachouche W; Bouzaiene H; Chargui R; Ben Hassouna J; Mtaalah MH; Dhiab T; Hechiche M; Benna F; Boussen H; Gamoudi A; Rahal K
Gynecol Obstet Fertil; 2007 Nov; 35(11):1117-22. PubMed ID: 17977045
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations and histological type of invasive breast carcinoma.
Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M
Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT).
Vu-Nishino H; Tavassoli FA; Ahrens WA; Haffty BG
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1040-7. PubMed ID: 15990007
[TBL] [Abstract][Full Text] [Related]
11. Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast.
Marginean F; Rakha EA; Ho BC; Ellis IO; Lee AH
Mod Pathol; 2010 Oct; 23(10):1357-63. PubMed ID: 20581807
[TBL] [Abstract][Full Text] [Related]
12. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Naidu R; Wahab NA; Yadav MM; Kutty MK
Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
[TBL] [Abstract][Full Text] [Related]
13. High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.
Jacquemier J; Bertucci F; Finetti P; Esterni B; Charafe-Jauffret E; Thibult ML; Houvenaeghel G; Van den Eynde B; Birnbaum D; Olive D; Xerri L
Int J Cancer; 2012 Jan; 130(1):96-104. PubMed ID: 21328335
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of BRCA1 expression in sporadic breast carcinomas.
Lambie H; Miremadi A; Pinder SE; Bell JA; Wencyk P; Paish EC; Macmillan RD; Ellis IO
J Pathol; 2003 Jun; 200(2):207-13. PubMed ID: 12754741
[TBL] [Abstract][Full Text] [Related]
15. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients.
Kurosumi M; Tabei T; Inoue K; Takei H; Ninomiya J; Naganuma R; Suemasu K; Higashi Y; Tsuchiya E
Oncol Rep; 2003; 10(4):833-7. PubMed ID: 12792731
[TBL] [Abstract][Full Text] [Related]
17. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
Falco M
Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
[TBL] [Abstract][Full Text] [Related]
18. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
Grönberg M; Fjällskog ML; Jirström K; Janson ET
Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
[TBL] [Abstract][Full Text] [Related]
19. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.
Nagao T; Kinoshita T; Hojo T; Tsuda H; Tamura K; Fujiwara Y
Breast; 2012 Jun; 21(3):289-95. PubMed ID: 22277312
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.
Lee AH; Pinder SE; Macmillan RD; Mitchell M; Ellis IO; Elston CW; Blamey RW
Eur J Cancer; 2006 Feb; 42(3):357-62. PubMed ID: 16377180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
